<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Cesarean birth: Preoperative planning and patient preparation
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Cesarean birth: Preoperative planning and patient preparation
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Cesarean birth: Preoperative planning and patient preparation
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Vincenzo Berghella, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            William Grobman, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Vanessa A Barss, MD, FACOG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 19, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cesarean birth (also called cesarean section) is one of the most common major surgical procedures performed in an operating room in the United States. Cesarean births comprise almost one-third of births in the United States [
         <a href="#rid1">
          1
         </a>
         ]. It is also a common procedure in many countries worldwide, and the rate is generally rising [
         <a href="#rid2">
          2
         </a>
         ]. Concerns about the rising rate have prompted medical organizations to suggest potential interventions to reduce the rate of unnecessary procedures, such as education, standardization, better childbirth preparation, second opinion before/peer review after a cesarean, broader midwifery-led care, more trials of labor after a cesarean, continuous labor support, multifaceted toolkits, changes in current financial incentives/disincentives, and process measures with rapid feedback [
         <a href="#rid3">
          3-6
         </a>
         ]. There is some evidence that implementation of a multifaceted approach to support vaginal birth can be effective in reducing cesarean births in nulliparous, term, singleton, vertex pregnancies [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         This topic will review preoperative planning and patient preparation for cesarean birth. Surgical technique, postoperative issues, repeat cesarean birth, cesarean birth on maternal request, and trial of labor after cesarean birth are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5405.html" rel="external">
          "Cesarean birth: Surgical technique"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4459.html" rel="external">
          "Cesarean birth: Postoperative care, complications, and long-term sequelae"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4457.html" rel="external">
          "Repeat cesarean birth"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4477.html" rel="external">
          "Cesarean birth on patient request"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4479.html" rel="external">
          "Choosing the route of delivery after cesarean birth"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Our approach is generally consistent with other evidenced-based protocols. The Enhanced Recovery After Surgery (ERAS) Society has published guidelines for perioperative care of patients undergoing cesarean birth, the ERAS Cesarean Delivery Guidelines, which cover the time from decision to operate (starting with the 30 to 60 minutes before skin incision) to hospital discharge [
         <a href="#rid8">
          8-10
         </a>
         ]. The American College of Obstetricians and Gynecologists has published a guideline for enhanced recovery after surgery [
         <a href="#rid11">
          11
         </a>
         ]. Other organizations and many hospitals have also created such guidelines/pathways [
         <a href="#rid12">
          12
         </a>
         ]. These approaches appear to reduce postoperative complications, reduce postoperative pain scores and opioid use, and shorten hospital stay without compromising readmission rates [
         <a href="#rid13">
          13-15
         </a>
         ]. However, guidelines vary and their recommendations are often based on expert opinion and evidence from observational studies.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          INDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cesarean birth is performed when the clinician and/or patient believe that abdominal birth is likely to provide a better maternal and/or fetal outcome than vaginal birth. Thus, indications for cesarean birth fall into two general categories:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Medically/obstetrically indicated
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         On maternal request
        </p>
        <p>
        </p>
        <p>
         Approximately 70 percent of cesarean births in the United States are primary (first) cesareans. The three most common indications for primary cesarean birth in the United States account for almost 80 percent of these births [
         <a href="#rid16">
          16
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Failure to progress during labor (35 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nonreassuring fetal status (24 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fetal malpresentation (19 percent)
        </p>
        <p>
        </p>
        <p>
         Additionally, less common indications for primary cesarean birth include, but are not limited to:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abnormal placentation (eg, placenta previa, placenta accreta spectrum, vasa previa)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Maternal infection with significant risk of perinatal transmission during vaginal birth
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Some fetal bleeding diatheses
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Funic (cord) presentation or cord prolapse
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Suspected macrosomia (typically 5000 grams in patients without diabetes, 4500 grams in patients with diabetes)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mechanical obstruction to vaginal birth (eg, large fibroid, severely displaced pelvic fracture, severe fetal hydrocephalus)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Uterine rupture
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prior extensive transmyometrial uterine surgery, such as some myomectomies and reconstructive surgeries used to repair congenital uterine anomalies
        </p>
        <p>
        </p>
        <p>
         Although infrequent, cesarean birth is also indicated in patients who are at increased risk for complications/injury from cervical dilation, descent and expulsion of the fetus, or episiotomy. Some examples include patients with invasive cervical cancer, active perianal inflammatory bowel disease, or history of repair of a rectovaginal fistula or pelvic organ prolapse. (See
         <a class="medical medical_review" href="/z/d/html/4805.html" rel="external">
          "Cervical cancer in pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4083.html" rel="external">
          "Fertility, pregnancy, and nursing in inflammatory bowel disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8079.html" rel="external">
          "Effect of pregnancy and childbirth on urinary incontinence and pelvic organ prolapse"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8086.html" rel="external">
          "Fecal and anal incontinence associated with pregnancy and childbirth: Counseling, evaluation, and management"
         </a>
         .)
        </p>
        <p>
         Cesarean birth on maternal request is uncommon, and discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4477.html" rel="external">
          "Cesarean birth on patient request"
         </a>
         .)
        </p>
        <p>
         Cesarean birth is not routinely indicated for low birth weight (see
         <a class="medical medical_review" href="/z/d/html/4444.html" rel="external">
          "Delivery of the low birth weight singleton cephalic fetus"
         </a>
         ), twin pregnancies (see
         <a class="medical medical_review" href="/z/d/html/4467.html" rel="external">
          "Twin pregnancy: Labor and delivery"
         </a>
         ), and most congenital anomalies. (Refer to topic reviews on individual anomalies.)
        </p>
        <p class="headingAnchor" id="H3119162810">
         <span class="h1">
          CONTRAINDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are no absolute contraindications to cesarean birth. In contrast to other types of surgery, the risks and benefits of the procedure are considered as they apply to two patients (mother and fetus). However, many pregnant individuals have a low tolerance for accepting any fetal risk from vaginal birth, irrespective of the maternal risks associated with cesarean birth [
         <a href="#rid17">
          17,18
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          PREOPERATIVE PLANNING
         </span>
        </p>
        <p class="headingAnchor" id="H1644848207">
         <span class="h2">
          Patient education/consent
         </span>
         <span class="headingEndMark">
          —
         </span>
         Good clinical practice involves counseling the patient about the procedure and the plan for their care before, during, and after the cesarean birth. A consent form for the procedure should be reviewed, including basic procedural information, risks, and benefits; all questions should be answered prior to signing. This information may diminish anxiety, help patients make well-informed choices relating to their care, and enhance postoperative recovery. (See
         <a class="medical medical_review" href="/z/d/html/117727.html" rel="external">
          "Informed consent in obstetrics"
         </a>
         .)
        </p>
        <p>
         As part of patient education, implications for future pregnancies should be discussed. These issues are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/4457.html" rel="external">
          "Repeat cesarean birth"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2975551508">
         <span class="h2">
          Checklists
         </span>
         <span class="headingEndMark">
          —
         </span>
         Checklists can be helpful in preoperative planning and are available from various organizations, such as the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Flibguides.und.edu%2Fob-gyn%2Fpatient-safety-checklists&amp;token=75ykFsVeRQlCU6VAKcaLAuxCJV0QLtqsz7KYpRLOKB0VhtNRC%2BjI5gheqRHBdRIxaTXJA2pzDj52aQhrW2e6iw%3D%3D&amp;TOPIC_ID=4475" target="_blank">
          American College of Obstetricians and Gynecologists
         </a>
         and
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ahrq.gov%2Fsites%2Fdefault%2Ffiles%2Fwysiwyg%2Fprofessionals%2Fquality-patient-safety%2Fhais%2Ftools%2Fperinatal-care%2Fmodules%2Fstrategies%2Flabor-delivery-unit%2Ftool_safe-csection.docx&amp;token=JDGUZKVA1f0eJJixk2jwLYjRoBEHxYGbSgPHyoO8B%2BRe7uvHC3N7bZBLe09n81e1BIUUgyAJobiPyeo1sc5KODtcdGjSOAQnASje%2FEtnWY1U3VgJ%2B%2FA%2Bx1cLThz3qrs7onTl4w%2B%2BIFCYVVEIa%2FSXI8bHpCgNCdH%2FG1MM9XukRlz9aUfAelKyzzvo1h5e9uSx&amp;TOPIC_ID=4475" target="_blank">
          Agency for Healthcare Research and Quality (AHRQ)
         </a>
         .
        </p>
        <p class="headingAnchor" id="H83427499">
         <span class="h2">
          Postpartum contraception
         </span>
         <span class="headingEndMark">
          —
         </span>
         Postpartum contraception plans should be discussed during prenatal care, and decisions made well before the intrapartum period. (See
         <a class="medical medical_review" href="/z/d/html/6708.html" rel="external">
          "Contraception: Postpartum counseling and methods"
         </a>
         .)
        </p>
        <p>
         For patients who are certain that they desire permanent contraception, the procedure can be performed at the time of cesarean birth. (See
         <a class="medical medical_review" href="/z/d/html/101560.html" rel="external">
          "Overview of female permanent contraception"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/101866.html" rel="external">
          "Postpartum permanent contraception: Procedures", section on 'Following cesarean birth'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Scheduling
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Medically or obstetrically indicated procedures
         </strong>
         — Medically/obstetrically indicated cesarean births are scheduled when clinically indicated. Indications for administration of a course of antenatal corticosteroids before preterm birth, if time permits, are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/6796.html" rel="external">
          "Antenatal corticosteroid therapy for reduction of neonatal respiratory morbidity and mortality from preterm delivery", section on 'Candidates for a first ACS course by gestational age'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         When a primary cesarean birth is indicated for maternal or fetal reasons, but preterm birth is not indicated, there is consensus that planned term cesarean birth should be scheduled in the 39
         <sup>
          th
         </sup>
         week of gestation [
         <a href="#rid19">
          19-21
         </a>
         ]. We caution against performing early term (in the 37
         <sup>
          th
         </sup>
         or 38
         <sup>
          th
         </sup>
         week of gestation) cesareans when the medical/obstetric indication for delivery is "soft," such as a history of fetal, maternal, or obstetric complication in a previous pregnancy that has not recurred.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In suboptimally dated pregnancies, scheduling should be based on the best clinical estimate of gestational age [
         <a href="#rid22">
          22
         </a>
         ]. Performing an amniocentesis for assessment of fetal lung maturity is not recommended as a component of this decision and is rarely, if ever, clinically indicated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         This approach is based on data from large, observational studies and randomized trials that consistently show that neonatal respiratory morbidity and/or composite neonatal morbidity is higher after planned cesarean birth and decreases as gestational age increases from 37 to 40 weeks [
         <a href="#rid23">
          23-31
         </a>
         ]. An example of the magnitude of these risks was provided by a study that evaluated adverse neonatal outcomes according to completed week of gestation in over 13,000 elective cesareans performed before the onset of labor [
         <a href="#rid32">
          32
         </a>
         ]. Birth before 39 weeks of gestation was associated with a statistically higher risk of respiratory and other adverse neonatal outcomes compared with birth at or after 39 weeks of gestation:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Rates of respiratory distress syndrome/transient tachypnea by gestational age were: 37 weeks (8.2 percent), 38 weeks (5.5 percent), 39 weeks (3.4 percent), 40 weeks (3 percent), and 41 weeks (5.2 percent)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Rates of any adverse outcome/death by gestational were: 37 weeks (15.3 percent), 38 weeks (11 percent), 39 weeks (8 percent), 40 weeks (7.3 percent), and 41 weeks (11.3 percent)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Planned repeat cesarean birth
         </strong>
         — Timing of planned repeat cesarean birth is based on the type of previous hysterotomy incision and is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/4457.html" rel="external">
          "Repeat cesarean birth", section on 'Timing'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cesarean birth on maternal request
         </strong>
         — Cesarean birth on maternal request is planned for the 39
         <sup>
          th
         </sup>
         week of gestation. (See
         <a class="medical medical_review" href="/z/d/html/4477.html" rel="external">
          "Cesarean birth on patient request"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3459056178">
         <span class="h2">
          Natural, gentle, or family-centered cesarean
         </span>
         <span class="headingEndMark">
          —
         </span>
         The "natural," "gentle," or "family-centered" cesarean birth approach was developed to improve the birth experience of patients having uncomplicated cesarean births. It attempts to replicate features of vaginal birth as much as possible to make cesarean surgery more family friendly. Components of this approach may include [
         <a href="#rid33">
          33,34
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Reduction of extraneous noise (eg, conversation among staff) and playing background music of the parent(s)' choice during birth.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dimming lights, when safely possible.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Using clear drapes or positioning the drapes to allow the parent(s) to watch the birth.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Avoiding maternal sedation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Allowing the newborn to be born by a combination of natural uterine expulsion and active physician assistance to mimic expulsion from the vagina.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Freeing the mother's dominant hand/arm and chest/breasts from lines and monitors, when possible, so they can hold and nurse the newborn.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Promoting skin-to-skin contact and nursing immediately after birth.
        </p>
        <p>
        </p>
        <p>
         Family-centered cesarean is preferred whenever feasible (ie, routinely unless an emergency cesarean needs to be performed). The parent(s) become an active part of the cesarean birth by directly observing the birth and by cutting the umbilical cord. In a randomized trial, family-centered cesarean was safe for both mother and newborn and led to a better birth experience, higher rate of breastfeeding, and improved early mother-infant interaction [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H409270524">
         <span class="h2">
          Intrapartum cesarean
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intrapartum cesarean births are sometimes classified by degree of urgency; for example: (1) an immediate threat to life of the mother or fetus is present, (2) signs of maternal or fetal compromise are present but are not immediately life threatening, or (3) delivery is needed, but there is no evidence of maternal or fetal compromise. Compared with planned cesarean birth, intrapartum cesarean is associated with increased risks of postpartum hemorrhage, anesthetic complications from rapid administration of general anesthesia, and accidental injury to the fetus or abdominopelvic organs.
        </p>
        <p>
         Although, historically, facilities providing obstetric services were asked to be capable of beginning an intrapartum cesarean birth within 30 minutes of the decision to perform the operation, this threshold was based upon the practical constraints many hospitals faced in assembling the appropriate team of nurses, anesthetists, and surgeons. The threshold was not evidence-based, universally achievable, or ideal from the perspective of decreasing perinatal or maternal mortality and morbidity [
         <a href="#rid36">
          36-45
         </a>
         ].
        </p>
        <p>
         The ability to begin an intrapartum cesarean birth within 30 minutes of the decision to operate is a reasonable benchmark for monitoring the quality of labor and delivery units, but not a requirement that all cesarean births be performed within 30 minutes of the decision. In human and animal studies, sudden complete anoxia, such as occurs with a total abruption or complete cord occlusion, probably necessitates delivery within five minutes to avoid fetal hypoxia [
         <a href="#rid46">
          46-48
         </a>
         ], although intact survivors have been reported after longer durations of severe hypoxia. Most pregnancies with less severe fetal or maternal compromise or partial or complete recovery of nonreassuring fetal heart rate tracings will have good outcomes despite intervals over 30 minutes before initiating surgery [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1049653698">
         <span class="h1">
          PREPROCEDURE MATERNAL PREPARATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H1982261853">
         <span class="h2">
          Skin self-cleansing
         </span>
         <span class="headingEndMark">
          —
         </span>
         A Centers for Disease Control (CDC) guideline for the prevention of surgical site infection
         <strong>
         </strong>
         suggests that patients shower or bathe (full body) with soap (nonantimicrobial or antimicrobial) or an antiseptic agent on at least the night before the day of any surgery [
         <a href="#rid49">
          49
         </a>
         ]. We do not advise patients to use any particular product to cleanse their skin before cesarean. A placebo-controlled randomized trial of pregnant individuals undergoing cesarean birth failed to show benefit with
         <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">
          chlorhexidine
         </a>
         [
         <a href="#rid50">
          50
         </a>
         ]. Meta-analyses of randomized trials of preoperative bathing or showering with chlorhexidine or other products before a variety of other surgical procedures have also found no clear reduction in surgical site infection rates [
         <a href="#rid51">
          51-54
         </a>
         ].
        </p>
        <p>
         Skin preparation in the operating room is discussed below. (See
         <a class="local">
          'Skin preparation'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1544709992">
         <span class="h2">
          Fasting and aspiration prophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Preoperative fasting (eg, two-hour fast for clear liquids, six-hour fast for solids, eight-hour fast for fatty meals before surgery but encourage clear liquids up to two hours before surgery) and administration of pharmacologic prophylaxis are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery", section on 'Preparation for anesthesia'
         </a>
         .)
        </p>
        <p>
         Some guidelines suggest that the clear liquids contain carbohydrate (eg, apple juice, Gatorade) in patients without diabetes [
         <a href="#rid12">
          12
         </a>
         ]. Encouraging fluids up to two hours prior to surgery and carbohydrate loading (45 grams is suggested) are thought to reduce preoperative anxiety, hypoglycemia, dehydration, thirst, and hunger. (See
         <a class="medical medical_review" href="/z/d/html/15698.html" rel="external">
          "Preoperative fasting in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Anesthesia consultation
         </span>
         <span class="headingEndMark">
          —
         </span>
         As with any surgical procedure, patients undergoing cesarean birth should have a preoperative consultation with the anesthesia team. Those whose procedure-related risks are above baseline should have a
         <strong>
          preadmission
         </strong>
         consultation, if possible. Characteristics that place the patient at increased risk may include, but are not limited to, those listed in the table  (
         <a class="graphic graphic_table graphicRef68666" href="/z/d/graphic/68666.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         The choice of regional or general anesthesia is influenced by factors such as the urgency of the procedure, maternal status and comorbid conditions, and physician and patient preference. Issues related to anesthesia for cesarean birth, including preanesthetic medications (eg, antacids, histamine H2 receptor antagonists) and oral intake, are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Laboratory testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         A baseline hemoglobin or hematocrit measurement is recommended for patients who are undergoing major surgery, such as cesarean birth, that is expected to result in significant blood loss. A value in the normal range obtained within one month of surgery probably does not need to be repeated preoperatively in uncomplicated pregnancies. (See
         <a class="medical medical_review" href="/z/d/html/4816.html" rel="external">
          "Preoperative medical evaluation of the healthy adult patient"
         </a>
         .)
        </p>
        <p>
         In the United States, The Joint Commission requires use of an evidence-based tool for determining maternal hemorrhage risk on admission to labor and delivery [
         <a href="#rid55">
          55
         </a>
         ]. Based on assessment of low, medium, or high risk of hemorrhage, blood is sent to the blood bank for holding in readiness, type and screen, or crossmatch, respectively. Methods of risk assessment and preparation for postpartum hemorrhage, a relatively common life-threatening emergency, are integral components of intrapartum care and reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/6710.html" rel="external">
          "Overview of postpartum hemorrhage"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Antibiotic prophylaxis
         </span>
        </p>
        <p class="headingAnchor" id="H2811425959">
         <span class="h3">
          Regimen
         </span>
         <span class="headingEndMark">
          —
         </span>
         For all patients not already on antibiotics and undergoing cesarean birth, we administer:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          Cefazolin
         </a>
         in the 60 minutes before making the skin incision [
         <a href="#rid56">
          56
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         &lt;120 kg – 2 g intravenously (IV)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         ≥120 kg – 3 g IV
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         PLUS a single dose of
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         500 mg intravenously for patients in labor or with ruptured membranes [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         PLUS antiseptic abdominal and vaginal cleansing preparation. (See
         <a class="local">
          'Skin preparation'
         </a>
         below and
         <a class="local">
          'Vaginal preparation'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p>
         The American College of Obstetricians and Gynecologists (ACOG) also recommends a single dose of a first-generation cephalosporin, but dosing is different (
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         1 g IV for patients &lt;80 kg, 2 to 3 g IV for patients ≥80 kg) [
         <a href="#rid58">
          58
         </a>
         ]. ACOG states that
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         may be considered in unplanned cesareans.
        </p>
        <p class="headingAnchor" id="H3266331340">
         <span class="h4">
          Evidence
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Benefits
         </strong>
         – In the absence of antimicrobial prophylaxis, patients undergoing cesarean birth have a 5- to 20-fold greater risk for infection compared with those who give birth vaginally [
         <a href="#rid59">
          59
         </a>
         ]. The benefit of antibiotic prophylaxis before cesarean birth was illustrated in a systematic review of randomized trials that compared maternal outcomes "with" versus "without" use of prophylactic antibiotics and found that antibiotic prophylaxis reduced the risk of endometritis by approximately 60 percent in both antepartum and intrapartum cesarean births (95 trials, &gt;15,000 participants) [
         <a href="#rid59">
          59
         </a>
         ]. The risks of wound infection, urinary tract infection, and serious maternal infectious complications were also reduced. In a smaller systematic review that evaluated neonatal outcomes (12 trials, &gt;5000 participants), nonstatistically significant reductions in neonatal sepsis (risk ratio [RR] 0.76, 95% CI 0.51-1.13) and neonatal infection with antimicrobial-resistant bacteria (RR 0.70, 95% CI 0.32-4.14) were reported, and would be clinically important if proven true when more robust data become available [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although the relative risk reduction in maternal infection is statistically significant and similar for both antepartum and intrapartum procedures, the absolute risk of maternal infection is quite low in antepartum cases: In a large observational study, postpartum endometritis occurred in 2 percent of patients with antibiotic prophylaxis versus 2.6 percent without antibiotic prophylaxis; wound infection occurred in 0.52 percent of patients with antibiotic prophylaxis versus 0.96 percent without antibiotic prophylaxis [
         <a href="#rid61">
          61
         </a>
         ]. Thus, 1000 patients undergoing antepartum cesarean birth would receive antibiotics to prevent 6 cases of endometritis and 4.4 cases of abdominal wound infection. The low risk of maternal infection in these cases and uncertainty about long-term effects in offspring have prompted a call for more research on potential long-term risks of exposure to antibiotic prophylaxis and strategies for risk stratification to identify the best candidates for antibiotic prophylaxis [
         <a href="#rid62">
          62
         </a>
         ]. Until these data are available, we administer antibiotics before all cesarean births, in accordance with ACOG guidelines [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Timing
         </strong>
         – Antimicrobial therapy should be administered within 60 minutes before making the skin incision to ensure adequate drug tissue levels [
         <a href="#rid58">
          58
         </a>
         ]. This recommendation is supported by a meta-analysis of randomized trials that compared infection rates in pregnant patients assigned to a single pre-incision dose of antibiotic prophylaxis versus those assigned to administration after cord clamping [
         <a href="#rid60">
          60
         </a>
         ]. Pre-incision prophylaxis was significantly more effective than delayed administration for prevention of endometritis (RR 0.54, 95% CI 0.36-0.79) and was not associated with an increase in proven neonatal sepsis, sepsis work-ups, or admission to the neonatal intensive care unit, although the trials had limited power to detect adverse neonatal effects. (See
         <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">
          "Antimicrobial prophylaxis for prevention of surgical site infection in adults", section on 'Timing'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Drug choice and dose
         </strong>
         – Comparative trials do not provide strong evidence on which to base a recommendation for the optimal drug and dose.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Broad spectrum single antibiotics
         </strong>
         – Based on expert opinion from infectious disease experts, we administer
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         , with dosing based on weight [
         <a href="#rid56">
          56
         </a>
         ]. The higher dose for patients with obesity is based on pharmacokinetic data rather than surgical site infection rates, and these data have been inconsistent [
         <a href="#rid63">
          63-67
         </a>
         ]. Cefazolin has a longer half-life than
         <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">
          ampicillin
         </a>
         (1.8 versus 0.7 to 1.5 hours in adults with normal renal function [
         <a href="#rid68">
          68
         </a>
         ]), which is an advantage in long surgeries. In a 2021 systematic review of randomized trials, first- and second-generation cephalosporins (eg, cefazolin,
         <a class="drug drug_general" data-topicid="9223" href="/z/d/drug information/9223.html" rel="external">
          cefoxitin
         </a>
         ) and broad-spectrum penicillins plus betalactamase inhibitors (eg,
         <a class="drug drug_general" data-topicid="8673" href="/z/d/drug information/8673.html" rel="external">
          amoxicillin
         </a>
         plus clavulanic acid, ampicillin plus sulbactam) appeared to be similarly effective for preventing postoperative maternal infection (endometritis, wound infection) after cesarean birth; use of adjunctive
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         to target
         <em>
          Ureaplasma
         </em>
         and
         <em>
          Mycoplasma
         </em>
         species was not evaluated [
         <a href="#rid69">
          69
         </a>
         ]. Other systematic reviews of randomized trials have noted that a single dose of antibiotics is as effective as multiple doses [
         <a href="#rid70">
          70,71
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Extended-spectrum antibiotic combinations
         </strong>
         – Additional data from randomized trials support use of extended-spectrum antibiotic combinations (eg,
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         plus
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         , cefazolin plus
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         ) for women at high risk of post-cesarean infection [
         <a href="#rid72">
          72
         </a>
         ]. In a seminal placebo-controlled multicenter randomized trial including over 2000 pregnant patients, administration of azithromycin 500 mg intravenously before skin incision in addition to preoperative cefazolin resulted in a 50 percent reduction in the composite outcome of endometritis, wound infection, or other infection (endometritis 3.8 versus 6.1 percent, wound infection 2.4 versus 6.6 percent; composite RR 0.51, 95% CI 0.38-0.68), without impacting the frequency of adverse neonatal outcomes [
         <a href="#rid57">
          57
         </a>
         ]. The authors also found that adjunctive azithromycin prophylaxis was cost-effective [
         <a href="#rid73">
          73
         </a>
         ]. Of note, only patients who had a cesarean birth during labor or at least four hours after rupture of membranes were included, so these data do not apply to other cesarean births (eg, antepartum cesarean births with intact membranes). Specific tests for
         <em>
          Ureaplasma
         </em>
         or
         <em>
          Mycoplasma
         </em>
         species were not routinely performed, thus it is not known whether coverage against
         <em>
          Ureaplasma
         </em>
         and
         <em>
          Mycoplasma
         </em>
         species provided by the extended antibiotic regimen accounted for the reduction in postoperative infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Ideally,
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         is infused within the 60 minutes before making the skin incision, but this may not be possible intrapartum. In the trial discussed above, the drug appeared to be effective regardless of timing of administration; 83 percent of patients received azithromycin 0 to 60 minutes before the skin incision, 5 percent received it &gt;60 minutes before the incision, and 12 percent received it after the incision was made [
         <a href="#rid57">
          57
         </a>
         ]. In a secondary analysis of these data, azithromycin administration was associated with a reduced risk of maternal postcesarean infection when administered within 60 minutes before skin incision and when administered after (median 3 minutes, range 0–229 minutes) skin incision [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Observational studies evaluating the use of
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         prophylaxis of prelabor cesarean births in patients with intact membranes have reported discordant results [
         <a href="#rid75">
          75,76
         </a>
         ]. No adequately powered randomized trial has evaluated adding azithromycin to
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         in this setting. Therefore, we continue to only use cefazolin for prophylaxis in patients with intact membranes not in labor.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Duration
         </strong>
         – Traditionally, prophylaxis has not been continued postpartum because studies in general surgical populations showed no benefit from postoperative antimicrobial prophylaxis. However, one trial in patients with obesity undergoing cesarean birth reported a benefit of antibiotic prophylaxis for 48 hours following the cesarean when given in addition to preoperative prophylaxis. These data are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/4452.html" rel="external">
          "Cesarean birth: Overview of issues for patients with obesity", section on 'Antibiotic prophylaxis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H720334636">
         <span class="h3">
          Special populations
         </span>
        </p>
        <p class="headingAnchor" id="H4212205391">
         <span class="h4">
          Patients with penicillin allergy
         </span>
         <span class="headingEndMark">
          —
         </span>
         These patients fall into two groups: those with previous serious reactions and those at low risk for a serious reaction.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For
         <strong>
          patients with a history of serious forms of penicillin allergy
         </strong>
         , we suggest a single dose of combination therapy [
         <a href="#rid56">
          56,58
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Antepartum cesarean with intact membranes:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          Clindamycin
         </a>
         900 mg IV
         <strong>
          plus
         </strong>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          Gentamicin
         </a>
         5 mg/kg IV
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Intrapartum cesarean or after rupture of membranes:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Add
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         500 mg IV to the combination above
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Serious forms of penicillin allergy include immediate reactions (ie, anaphylactic)  (
         <a class="graphic graphic_table graphicRef100732" href="/z/d/graphic/100732.html" rel="external">
          table 2
         </a>
         ), as well several types of delayed reactions (Stevens-Johnson syndrome [SJS], toxic epidermal necrolysis [TEN], drug rash eosinophilia systemic symptoms [DRESS], drug-induced liver or other organ injury, and drug-induced cytopenias).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         When
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         is used for prophylaxis in combination with a parenteral antimicrobial with activity against anaerobic agents, we advise 4.5 to 5 mg/kg of gentamicin as a single dose as many studies support the safety and efficacy of this dose when used as a single dose for prophylaxis in patients without renal insufficiency. In addition, a trial of antibiotic prophylaxis in colorectal surgery reported that this dose may be more effective than multiple standard doses of 1.5 mg/kg during prolonged surgeries [
         <a href="#rid77">
          77
         </a>
         ]. However, cesarean birth typically takes less than an hour; thus, a lower dose of gentamicin may be adequate; there are no comparative dosing trials in this population. Single daily dose gentamicin dosing does not appear be associated with more neonatal nephrotoxicity or auditory toxicity than multiple daily doses [
         <a href="#rid78">
          78
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For
         <strong>
          patients at low risk of a serious immediate allergic reaction
         </strong>
         ,
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         can be administered, as described above (see
         <a class="local">
          'Regimen'
         </a>
         above). The risk of a penicillin-allergic patient reacting to a cephalosporin may be assessed based upon the results of penicillin skin testing (ideally performed prenatally), the clinical features of the penicillin reaction, and the time elapsed since the last reaction to penicillin  (
         <a class="graphic graphic_algorithm graphicRef112936" href="/z/d/graphic/112936.html" rel="external">
          algorithm 1
         </a>
         ). If cesarean is performed intrapartum or after rupture of membranes, we add
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         500 mg intravenously. (See
         <a class="medical medical_review" href="/z/d/html/2087.html" rel="external">
          "Allergy evaluation for immediate penicillin allergy: Skin test-based diagnostic strategies and cross-reactivity with other beta-lactam antibiotics"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2073.html" rel="external">
          "Penicillin allergy: Immediate reactions"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2045787177">
         <span class="h4">
          Patients already on antibiotics
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are no randomized trials assessing efficacy of antibiotic regimens in these clinical scenarios.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients receiving GBS prophylaxis
         </strong>
         – When cesarean birth is performed in a patient in labor or with ruptured membranes receiving
         <a class="drug drug_general" data-topicid="9749" href="/z/d/drug information/9749.html" rel="external">
          penicillin G
         </a>
         for neonatal Group B
         <em>
          Streptococcus
         </em>
         (GBS) prophylaxis, we do not add a cephalosporin or switch to
         <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">
          ampicillin
         </a>
         for surgical prophylaxis, but we add a 500 mg dose of
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         . Alternatively, some clinicians add a single dose of a narrow-spectrum antibiotic (eg,
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         ) as well as a dose of azithromycin to the penicillin G protocol for GBS prophylaxis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients with chorioamnionitis
         </strong>
         –
         <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">
          Ampicillin
         </a>
         plus
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         is a common regimen for treatment of chorioamnionitis. For patients already on this regimen, we also administer either one dose of
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         900 mg or
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         500 mg before beginning the cesarean. We do not administer
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         to these patients.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Postpartum, it is reasonable to either continue
         <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">
          ampicillin
         </a>
         plus
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         or switch to
         <a class="drug drug_general" data-topicid="8745" href="/z/d/drug information/8745.html" rel="external">
          ampicillin-sulbactam
         </a>
         until the patient is afebrile for at least 24 hours.
         <em>
          Bacteroides
         </em>
         resistance to
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         is increasing, thus, in areas of high resistance, ampicillin-sulbactam is preferable. (See
         <a class="medical medical_review" href="/z/d/html/6762.html" rel="external">
          "Clinical chorioamnionitis", section on 'Postpartum care'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1570076460">
         <span class="h4">
          Prolonged surgery or excessive blood loss
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antibiotic levels fall over time and with blood loss. Although redosing is the standard of care in other surgeries, there are no specific data for cesarean birth [
         <a href="#rid79">
          79
         </a>
         ]. A second dose of
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         is reasonable in patients with postpartum hemorrhage &gt;1500 mL [
         <a href="#rid58">
          58
         </a>
         ]. A second dose of cefazolin is also appropriate for the rare complicated cesarean birth that extends beyond four hours since the half-lives of cefazolin and
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         are approximately 1.8 and 68 hours, respectively.
        </p>
        <p>
         A joint guideline of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Surgical Infection Society, and the Society for Healthcare Epidemiology of America suggests consideration of additional intraoperative doses in patients with excessive blood loss (&gt;1500 mL) or extended surgery (duration exceeding two half-lives of the drug) [
         <a href="#rid56">
          56,80
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2183461245">
         <span class="h4">
          Nasal colonization with methicillin-resistant S. aureus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Routine screening for MRSA is not indicated. Management of patients known to be colonized (eg, addition of a single dose of
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         ) is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">
          "Antimicrobial prophylaxis for prevention of surgical site infection in adults", section on 'Role of vancomycin'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Thromboembolism prophylaxis
         </span>
        </p>
        <p class="headingAnchor" id="H97456436">
         <span class="h3">
          Risk of venous thromboembolism and pulmonary embolism
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pulmonary embolism is a common cause of maternal mortality [
         <a href="#rid81">
          81
         </a>
         ] and over 80 percent of fatal puerperal pulmonary embolism occurs after cesarean birth [
         <a href="#rid82">
          82
         </a>
         ]; however, the absolute level of risk for clinically important events is low and similar to that seen in very low-risk surgical patients, in whom routine thromboprophylaxis is not recommended (other than early ambulation). The incidence of postpartum thrombotic events is described separately. (See
         <a class="medical medical_review" href="/z/d/html/4459.html" rel="external">
          "Cesarean birth: Postoperative care, complications, and long-term sequelae", section on 'Venous thromboembolism'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5787987">
         <span class="h3">
          Our approach
         </span>
         <span class="headingEndMark">
          —
         </span>
         The value of thromboprophylaxis for cesarean birth has not been studied in adequately powered, randomized trials that have assessed and quantified both benefits (prevention of venous thrombosis and/or pulmonary embolism) and harms (wound or bleeding complications, including unplanned surgical procedures and blood transfusions) [
         <a href="#rid83">
          83-85
         </a>
         ]. International guidelines for thromboprophylaxis after cesarean differ markedly in selection of patients for thromboprophylaxis because both the optimal threshold for initiating pharmacologic thromboprophylaxis and optimal duration of therapy are unclear [
         <a href="#rid86">
          86
         </a>
         ]. Furthermore, no easy-to-use, validated tool is available for accurately determining absolute risk of postpartum VTE in an individual patient, although pilot studies of such tools have been published [
         <a href="#rid87">
          87,88
         </a>
         ]. Clinical validation is difficult given the relatively low incidence of VTE.
        </p>
        <p>
         This is our approach, which is generally consistent with ACOG recommendations [
         <a href="#rid89">
          89
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Low-risk patients
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We place a pneumatic compression device on all patients before cesarean birth
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We encourage early ambulation after cesarean birth, as soon as eight hours postoperatively
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We continue pneumatic compression until the patient is fully ambulatory [
         <a href="#rid90">
          90
         </a>
         ]. Pneumatic compression devices may be removed while the patient is ambulating but should be put back on when they return to a seated or supine position. Observational studies of pregnant patients suggest that pneumatic compression devices, as well as graduated compression stockings, are safe and effective [
         <a href="#rid91">
          91,92
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          High-risk patients
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We use both mechanical and pharmacologic thromboprophylaxis in patients at high risk of VTE undergoing cesarean birth
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We encourage early ambulation after cesarean birth, as soon as eight hours postoperatively
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Criteria for selecting patients at high risk are challenging as high-quality data are not available [
         <a href="#rid93">
          93
         </a>
         ]. We consider any of the following reasonable criteria for mechanical plus pharmacologic prophylaxis:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Previous VTE.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Any thrombophilia (inherited or acquired).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Body mass index (BMI) &gt;35 kg/m
         <sup>
          2
         </sup>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         ≥2 less prominent risk factors for VTE – Numerous less prominent risk factors for VTE are described in the literature (eg, postpartum hemorrhage or infection, medical factors or pregnancy complications such as obesity, hypertension, autoimmune disease, heart disease, sickle cell disease, multiple gestation, preeclampsia); ACCP and RCOG risk factors are described below [
         <a href="#rid94">
          94-105
         </a>
         ] (see
         <a class="local">
          'ACCP recommendations'
         </a>
         below and
         <a class="local">
          'RCOG recommendations'
         </a>
         below).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         The type and number of less prominent risk factors that meet the threshold for administering pharmacologic prophylaxis is decided on a case-by-case basis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Timing of initiation of pharmacologic therapy
         </strong>
         – Pharmacologic prophylaxis is generally begun 6 to 12 hours after cesarean birth to minimize bleeding complications, unless there is significant bleeding or risk for significant bleeding [
         <a href="#rid89">
          89
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The following timing considerations apply to patients who underwent a neuraxial procedure (see
         <a class="medical medical_review" href="/z/d/html/14930.html" rel="external">
          "Neuraxial anesthesia/analgesia techniques in the patient receiving anticoagulant or antiplatelet medication"
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines [
         <a href="#rid106">
          106
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Prophylactic dose low molecular weight heparin (LMWH) – Wait 6 to 12 hours after birth and no sooner than 4 hours after epidural catheter removal (whichever is later).
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Therapeutic dose LMWH – Wait 24 hours after birth, as long as hemostasis is ensured and epidural placement was not bloody or traumatic. Intravenous heparin can be used as a bridge if therapeutic anticoagulation is desired &lt;24 hours after birth.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants [
         <a href="#rid107">
          107
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Prophylactic dose subcutaneous
         <a class="drug drug_general" data-topicid="8518" href="/z/d/drug information/8518.html" rel="external">
          unfractionated heparin
         </a>
         (UFH) – Wait ≥1 hour after a neuraxial block and ≥1 hour after epidural catheter removal.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Prophylactic dose LMWH – Wait ≥12 hours after a neuraxial block and ≥4 hours after epidural catheter removal.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Therapeutic dose LMWH – Consider waiting ≥24 hours after a neuraxial block and ≥4 hours after epidural catheter removal. In select circumstances, UFH can be used as a bridge because it can be restarted sooner than LMWH.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Heparin dosing
         </strong>
         – UFH or LMWH (eg,
         <a class="drug drug_general" data-topicid="9407" href="/z/d/drug information/9407.html" rel="external">
          enoxaparin
         </a>
         ) can be used. In the absence of an indication for therapeutic-dose anticoagulation (eg, higher-risk thrombophilia), we generally prefer a LWMH at a low dose given once a day based on evidence from a large trial that it is as effective as intermediate dosing in VTE prevention [
         <a href="#rid108">
          108
         </a>
         ]. For example:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Body weight &lt;100 kg
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <a class="drug drug_general" data-topicid="9407" href="/z/d/drug information/9407.html" rel="external">
          Enoxaparin
         </a>
         40 mg (4000 units)
         <strong>
          or
         </strong>
         <a class="drug drug_general" data-topicid="9319" href="/z/d/drug information/9319.html" rel="external">
          dalteparin
         </a>
         5000 units subcutaneously once daily [
         <a href="#rid108">
          108
         </a>
         ]
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Alternatively, if LMWH is unavailable or contraindicated, UFH 5000 units subcutaneously every 12 hours
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Body weight ≥100 kg
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <a class="drug drug_general" data-topicid="9407" href="/z/d/drug information/9407.html" rel="external">
          Enoxaparin
         </a>
         60 mg (6000 units)
         <strong>
          or
         </strong>
         <a class="drug drug_general" data-topicid="9319" href="/z/d/drug information/9319.html" rel="external">
          dalteparin
         </a>
         7500 units subcutaneously daily [
         <a href="#rid108">
          108
         </a>
         ]
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Alternatively, if LMWH is unavailable or contraindicated, UFH 5000 units subcutaneously every eight hours
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients who require prolonged anticoagulation can be switched to an oral agent (eg,
         <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">
          warfarin
         </a>
         [can be used during lactation] or a direct oral anticoagulant [should not be used during lactation]). (See
         <a class="medical medical_review" href="/z/d/html/1342.html" rel="external">
          "Use of anticoagulants during pregnancy and postpartum", section on 'Postpartum and breastfeeding'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Duration of mechanical and pharmacologic prophylaxis
         </strong>
         – Pneumatic compression devices should be left in place until pharmacologic prophylaxis has been started. We generally continue the device until the patient is discharged as it may offer additive benefit to surgical patients on heparin. (See
         <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">
          "Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Pharmacologic prophylaxis is continued until the patient is fully ambulating,
         <strong>
          except
         </strong>
         for those with significant risk factors for postpartum VTE. Patients with a prior VTE should receive at least six weeks of thromboprophylaxis. Those with a VTE during the index pregnancy are treated for at least three months and this duration should include the remainder of pregnancy and at least six weeks postpartum. Those with a high risk thrombophilia may require an indefinite period of anticoagulation. (See
         <a class="medical medical_review" href="/z/d/html/1342.html" rel="external">
          "Use of anticoagulants during pregnancy and postpartum", section on 'Duration of postpartum anticoagulation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94740.html" rel="external">
          "Selecting adult patients with lower extremity deep venous thrombosis and pulmonary embolism for indefinite anticoagulation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6813.html" rel="external">
          "Antiphospholipid syndrome: Obstetric implications and management in pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4792.html" rel="external">
          "Inherited thrombophilias in pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1350.html" rel="external">
          "Venous thromboembolism in pregnancy and postpartum: Treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4154471344">
         <span class="h3">
          Recommendations of others
         </span>
        </p>
        <p class="headingAnchor" id="H5788092">
         <span class="h4">
          ACCP recommendations
         </span>
         <span class="headingEndMark">
          —
         </span>
         This is a partial synopsis of 2012
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3278054%2F&amp;token=wEsKVFvqlKzpT%2BqOtddW%2F9WyS2%2BmbISD1cPa9SCgRnci8vyKZ2%2Fmnf2fB28fHUVWbyfT4ibTlv2WqYqv2C7jCg%3D%3D&amp;TOPIC_ID=4475" target="_blank">
          ACCP guidelines for antithrombotic therapy and prevention of thrombosis in pregnancy
         </a>
         [
         <a href="#rid94">
          94
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients whose only risk factors for VTE are pregnancy and cesarean birth, the ACCP recommends only early ambulation postpartum.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients undergoing cesarean birth with one additional major risk factor for VTE or at least two additional minor risk factors for VTE, the ACCP recommends pharmacologic thromboprophylaxis while in the hospital following birth. If anticoagulants are contraindicated, graduated compression stockings or a pneumatic compression device is recommended.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients undergoing cesarean birth who are very high risk for VTE and have multiple additional risk factors for VTE that persist in the puerperium, the ACCP recommends pharmacologic thromboprophylaxis PLUS graduated compression stockings and/or pneumatic compression devices while in the hospital following birth.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For selected high-risk patients in whom significant risk factors persist after giving birth, the ACCP suggests extended pharmacologic prophylaxis for up to 6 weeks following discharge from the hospital.
        </p>
        <p>
        </p>
        <p>
         In 2016, several of the ACCP authors slightly revised the original risk factor criteria [
         <a href="#rid109">
          109
         </a>
         ]
         <em>
          .
         </em>
         Their most recent guidance for prevention of VTE after cesarean birth states:
        </p>
        <p>
         Prophylaxis should be provided after cesarean birth to patients with the following risk factors:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         One or more of: prior VTE, history of antepartum immobilization (strict bedrest for at least 1 week), significant postpartum infection, postpartum hemorrhage ≥1000 mL requiring reoperation, preeclampsia with growth restriction, significant medical co-morbidities (systemic lupus erythematosus, heart disease, or sickle cell disease), or a known thrombophilia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Two or more of (or one or more in the setting of emergency cesarean birth): postpartum hemorrhage ≥1000 mL not requiring reoperation, BMI &gt;30 kg/m
         <sup>
          2
         </sup>
         , fetal growth restriction, preeclampsia, multiple pregnancy, and tobacco use during pregnancy (≥10 cigarettes/day).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5788098">
         <span class="h4">
          RCOG recommendations
         </span>
         <span class="headingEndMark">
          —
         </span>
         The
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.rcog.org.uk%2Fglobalassets%2Fdocuments%2Fguidelines%2Fgtg-37a.pdf&amp;token=ctvKwPxgWhlk6Xn6fuW7lp4BrjelzKiVHfiKx7usiuGqXAqJ%2FTkszsIvNimdhVsP%2BtiqfFLdZoG8N2J8uLm4NHCdFQOV6tMATCJIt9%2FYZc4%3D&amp;TOPIC_ID=4475" target="_blank">
          Royal College of Obstetricians and Gynaecologists
         </a>
         (RCOG) stated that "all women who have had caesarean sections should be considered for thromboprophylaxis with LMWH for 10 days after delivery, apart from those having an elective caesarean section who should be considered for thromboprophylaxis with LMWH for 10 days after delivery if they have any additional risk factors. Thromboprophylaxis should be continued for six weeks in high-risk women and for 10 days in intermediate-risk women" [
         <a href="#rid105">
          105
         </a>
         ].
        </p>
        <p>
         The RCOG considers the following risk factors for VTE (refer to RCOG guideline for detailed description of risk assessment): previous VTE, thrombophilia, some medical comorbidities (eg, cancer; heart failure; active SLE, inflammatory polyarthropathy, or bowel disease; nephrotic syndrome; type I diabetes mellitus with nephropathy; sickle cell disease; current intravenous drug user), age &gt;35 years, BMI ≥30 kg/m
         <sup>
          2
         </sup>
         , parity ≥3, gross varicose veins (symptomatic or above knee or with associated phlebitis, edema/skin changes), paraplegia, multiple pregnancy, preeclampsia, preterm birth, postpartum hemorrhage &gt;1 L/requiring transfusion, admission/immobility ≥3 days, current systemic infection [
         <a href="#rid105">
          105
         </a>
         ].
        </p>
        <p>
         However, RCOG criteria for thromboprophylaxis after cesarean birth would apply to half of United States cesarean birth patients (1.2 million a year), and the drugs alone could cost up to USD $52 million for a 4-day course and USD $130 million for a 10-day course [
         <a href="#rid93">
          93
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H642711784">
         <span class="h2">
          Postpartum hemorrhage prophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         An evidence-based tool should be used to determine maternal hemorrhage risk and, in turn, appropriate preparations for the specific individual's degree of risk. (See
         <a class="medical medical_review" href="/z/d/html/6710.html" rel="external">
          "Overview of postpartum hemorrhage", section on 'Institutional planning and preparation'
         </a>
         .)
        </p>
        <p>
         We often administer
         <a class="drug drug_general" data-topicid="10011" href="/z/d/drug information/10011.html" rel="external">
          tranexamic acid
         </a>
         before making the skin incision and then administer routine uterotonic drug prophylaxis (eg,
         <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">
          oxytocin
         </a>
         ,
         <a class="drug drug_general" data-topicid="8562" href="/z/d/drug information/8562.html" rel="external">
          carbetocin
         </a>
         ) after delivery of the anterior shoulder. This is an increasingly common approach for prophylaxis against postpartum hemorrhage, even in low-risk patients, and reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/4437.html" rel="external">
          "Management of the third stage of labor: Prophylactic pharmacotherapy to minimize hemorrhage"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2443254462">
         <span class="h2">
          Prevention of nausea and vomiting
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nausea with or without vomiting occurs commonly during cesarean with neuraxial anesthesia. Prophylaxis for intraoperative and postoperative nausea and vomiting is routine. (See
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery", section on 'Preventing nausea and vomiting'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3786976565">
         <span class="h2">
          Other issues to consider
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bowel preparation
         </strong>
         (oral and/or mechanical) is not beneficial and is not recommended [
         <a href="#rid8">
          8,110
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Surgery in patients with
         <strong>
          severe obesity
         </strong>
         presents additional challenges that are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4452.html" rel="external">
          "Cesarean birth: Overview of issues for patients with obesity"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2643605446">
         <span class="h1">
          FETOPLACENTAL ASSESSMENT
         </span>
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Fetal heart rate monitoring
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients waiting to undergo a planned cesarean birth, the value of continuous or intermittent fetal heart rate monitoring following admission is unclear [
         <a href="#rid111">
          111
         </a>
         ], no randomized trials examining this issue have been performed. At a minimum, the fetal heart rate should be documented upon admission, similar to other vital signs. If the patient has been undergoing antepartum fetal testing, it is reasonable to perform an admission nonstress test and discontinue monitoring if the tracing is reactive. If there is an excessive delay between anesthetic placement and abdominal preparation for surgery, it is appropriate to recheck the fetal heart rate during this interval.
        </p>
        <p>
         For laboring patients, fetal heart rate monitoring should continue after transfer to the operating room, to the extent possible. External monitors are removed when the abdominal preparation is begun; internal monitors may be removed when the abdominal preparation is completed, although in some cases surgeons may elect to continue monitoring until birth, especially if the incision to delivery interval may be prolonged because of adhesions or other factors.
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Fetal presentation and placental location
         </span>
         <span class="headingEndMark">
          —
         </span>
         An ultrasound for assessment of placental location and fetal presentation (or abdominal examination to assess fetal presentation) may be useful before surgery, but is not routinely required. This information is helpful in selected patients. For example, it may help the surgeon avoid disturbing an anterior placenta or fibroid at hysterotomy and may help with plan the delivery of a fetus in nonvertex presentation.
        </p>
        <p class="headingAnchor" id="H2265027816">
         <span class="h1">
          INTRAOPERATIVE MATERNAL PREPARATION
         </span>
        </p>
        <p class="headingAnchor" id="H2242050665">
         <span class="h2">
          Room temperature
         </span>
         <span class="headingEndMark">
          —
         </span>
         Normothermia should be maintained during anesthesia and surgery. Patients receiving neuraxial anesthesia become hypothermic to a degree that is similar to those having general anesthesia. (See
         <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">
          "Perioperative temperature management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1271974742">
         <span class="h2">
          Music
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients undergoing a cesarean birth, music was associated with decreased intraoperative anxiety in a meta-analysis of randomized trials [
         <a href="#rid112">
          112
         </a>
         ]. Therefore, we suggest asking patients their preference for having or not having music, and what kind of music they would like during the cesarean.
        </p>
        <p class="headingAnchor" id="H3957890803">
         <span class="h2">
          Supplemental oxygen
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no benefit in maternal or perinatal clinical outcomes from routine administration of extra oxygen during cesarean birth [
         <a href="#rid113">
          113
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Bladder catheterization
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no high-quality evidence that routine placement of an indwelling catheter is advantageous [
         <a href="#rid114">
          114,115
         </a>
         ]. As an alternative, patients at low risk of intraoperative complications can be asked to void shortly before entering the operating room. If subsequently required, an indwelling catheter can be inserted intraoperatively or postoperatively, and removed as soon as possible [
         <a href="#rid116">
          116-119
         </a>
         ].
        </p>
        <p>
         Nevertheless, many clinicians insert a urethral catheter at the start of the case to maintain bladder drainage and thereby improve visualization during surgery and minimize bladder injury. The catheter is also useful for instilling dye if a cystotomy is suspected and for monitoring urine output. Potential harms include an increased risk of urinary tract infection, urethral pain, voiding difficulties after removal of the catheter, delayed ambulation, and longer hospital stay [
         <a href="#rid115">
          115
         </a>
         ]. If inserted, the catheter should be removed soon after the end of the cesarean [
         <a href="#rid120">
          120
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Hair removal
         </span>
         <span class="headingEndMark">
          —
         </span>
         Meta-analyses of randomized trials in nonpregnant patients report no difference in the rate of surgical site infection (SSI) in those who had hair removed prior to surgery versus those who did not [
         <a href="#rid121">
          121,122
         </a>
         ]. No randomized trials assessing this intervention specifically before cesarean birth have been performed.
        </p>
        <p>
         If hair needs to be removed, it should be clipped rather than shaved as patients who are shaved are more likely to develop SSI. Use of a depilatory cream is also preferable to shaving. Clipping should be performed just before surgery. (See
         <a class="medical medical_review" href="/z/d/html/4044.html" rel="external">
          "Overview of control measures for prevention of surgical site infection in adults", section on 'Hair removal'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h2">
          Skin preparation
         </span>
         <span class="headingEndMark">
          —
         </span>
         We prepare the abdominal surgical site with a chlorhexidine-alcohol scrub before cesarean birth based on data from three randomized trials that reported a reduction in SSI or positive bacterial wound cultures compared with iodine-alcohol skin preparation; two trials were in patients undergoing cesarean birth [
         <a href="#rid123">
          123,124
         </a>
         ] and the other in adults undergoing clean-contaminated surgery [
         <a href="#rid125">
          125
         </a>
         ].
        </p>
        <p>
         However, use of iodine-alcohol, povidone-iodine, or
         <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">
          chlorhexidine
         </a>
         soap is also reasonable. Alcohol-based surgical prep solutions contain approximately 70 to 75 percent isopropyl alcohol and serve as fuels if not allowed to dry sufficiently before use of an ignition source; at least three minutes are required. Therefore, preparation with povidone-iodine or chlorhexidine soap (eg, Hibiclens) is advantageous when surgery cannot be delayed, as these solutions are not flammable.
        </p>
        <p>
         A 2020 meta-analysis of randomized trials evaluating skin preparation techniques concluded there was insufficient evidence overall for determining the most effective skin preparation technique for preventing post-cesarean SSI or for reducing other undesirable outcomes [
         <a href="#rid126">
          126
         </a>
         ]. Of note, in the subanalysis comparing chlorhexidine-alcohol versus povidone-iodine, chlorhexidine-alcohol was more effective in reducing SSI (risk ratio [RR] 0.72, 95% CI 0.58-0.91, eight trials, 4323 patients), but the difference was attenuated when four trials at high risk of bias were removed. The American College of Obstetricians and Gynecologists and the Enhanced Recovery After Surgery (ERAS) Society guideline for intraoperative care in cesarean birth recommend use of an alcohol-based mixed solution, such as chlorhexidine-alcohol [
         <a href="#rid9">
          9,58
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1425764254">
         <span class="h2">
          Vaginal preparation
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients in labor and patients with ruptured membranes, the author of this topic performs a 4%
         <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">
          chlorhexidine
         </a>
         gluconate vaginal scrub with a sponge stick for 30 seconds with three passes to lower SSI risk, particularly endometritis. Povidone-iodine is a reasonable alternative but was less effective in one of the largest randomized trials comparing these two options [
         <a href="#rid127">
          127
         </a>
         ]. Importantly, preparations with a high alcohol content (chlorhexidine gluconate with 70% alcohol used for skin preparation) should be avoided in the vagina because alcohol irritates mucous membranes [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
         In a 2020 meta-analysis of randomized trials
         <sup>
         </sup>
         of vaginal cleansing (povidone-iodine or
         <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">
          chlorhexidine
         </a>
         ) versus
         <sup>
         </sup>
         placebo/no intervention before cesarean birth, vaginal cleansing resulted in reductions in endometritis (3 versus 7.2 percent, RR 0.41, 95% CI 0.29-0.58), postoperative fever (RR 0.64, 95% CI 0.50-0.82), and wound infection (3.8 versus 6.1 percent, RR 0.62, 95% CI 0.50-0.77) [
         <a href="#rid128">
          128
         </a>
         ]. Neither cleansing agent resulted in adverse effects. In subgroup analysis, the benefits were present whether iodine-based or chlorhexidine-based solutions were used and greatest in patients in labor or with ruptured membranes before the cesarean. However, a subsequent randomized trial specifically comparing precesarean abdominal plus vaginal cleansing (povidone-iodine) in patients in labor, with rupture of membranes, or with cervical dilation &gt;4 cm found no significant difference in postoperative infectious morbidity compared with abdominal cleansing alone (11.8 versus 11.5 percent; RR 1.0, 95% CI 0.7-1.6) [
         <a href="#rid129">
          129
         </a>
         ].
        </p>
        <p>
         A network meta-analysis of randomized trials confirmed that all antiseptic formulations (povidone-iodine,
         <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">
          chlorhexidine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         gel, cetrimide) decreased the rate of endometritis compared with placebo (5.2 versus 9.1 percent, odds ratio [OR] 0.48, 95% CI 0.35-0.65); povidone-iodine had the highest probability of reducing the risk of endometritis, postoperative wound infections, and fever [
         <a href="#rid130">
          130
         </a>
         ]. In the only trial that compared wound infection rates in patients assigned to chlorhexidine versus povidone-iodine before cesarean birth, the rate was lower in the chlorhexidine arm (0.6 versus 2 percent, OR 0.28, 95% CI 0.08-0.98) [
         <a href="#rid127">
          127
         </a>
         ], which is the basis for the author’s preference for chlorhexidine. Endometritis rates were low and similar in both arms (0.4 and 0.5 percent).
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h2">
          Nonadhesive drapes
         </span>
         <span class="headingEndMark">
          —
         </span>
         The surgical site is draped with nonadhesive drapes as a meta-analysis of two randomized trials in patients undergoing cesarean birth found that nonadhesive drapes resulted in a statistically significant reduction in the rate of wound infection compared with adhesive drapes (10.7 versus 13.8 percent) [
         <a href="#rid131">
          131
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h2">
          Uterine displacement
         </span>
         <span class="headingEndMark">
          —
         </span>
         The uterus is typically displaced at least 15 degrees to the left to reduce aortocaval compression (supine hypotensive syndrome), which can occur in the supine position when the uterus is at or above the umbilicus [
         <a href="#rid132">
          132-136
         </a>
         ]. A foam or wood wedge, pillow, or rolled blanket may be used, or the table can be tilted, or the uterus can be manually displaced. A systematic review was not able to determine the optimum method or maternal position [
         <a href="#rid137">
          137
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery", section on 'Intraoperative positioning'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H106030320">
         <span class="h2">
          Perioperative management of medication
         </span>
         <span class="headingEndMark">
          —
         </span>
         Perioperative medication management is similar to that for other surgical procedures, and discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4814.html" rel="external">
          "Perioperative medication management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H990070021">
         <span class="h2">
          Hemodynamic management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Preoperative and intraoperative euvolemia are desirable to avoid maternal and fetal complications of hypotension or fluid overload. The anesthesia team aims to maintain blood pressure within 10 to 20 percent of baseline blood pressure unless the patient has severe hypertension. Crystalloid solutions are used more commonly than colloid solutions. Glucose-free solutions should be used to prevent neonatal hypoglycemia. Vasopressors may be administered prophylactically and as needed. (See
         <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">
          "Anesthesia for cesarean delivery", section on 'Hemodynamic management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2910101826">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/113175.html" rel="external">
          "Society guideline links: Cesarean birth"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3317586">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15611.html" rel="external">
          "Patient education: Cesarean birth (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/6728.html" rel="external">
          "Patient education: C-section (cesarean delivery) (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications
         </strong>
         – Cesarean birth is performed when the clinician and patient believe that abdominal delivery is likely to provide a better maternal or fetal outcome than vaginal delivery. A wide variety of conditions fulfill these criteria. (See
         <a class="local">
          'Indications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Scheduling planned cesareans
         </strong>
         – Planned primary cesarean birth at term should be performed in the 39
         <sup>
          th
         </sup>
         week of gestation rather than in the 37
         <sup>
          th
         </sup>
         or 38
         <sup>
          th
         </sup>
         week. Medically/obstetrically indicated cesarean births are performed when clinically indicated. (See
         <a class="local">
          'Scheduling'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Timing of planned repeat cesarean birth is based on the type of previous hysterotomy incision and is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/4457.html" rel="external">
          "Repeat cesarean birth", section on 'Timing'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postpartum hemorrhage prophylaxis
         </strong>
         – An evidence-based tool should be used for determining maternal hemorrhage risk on admission to labor and delivery. Based on assessment of low, medium, or high risk of hemorrhage, blood is sent to the blood bank for holding in readiness, type and screen, or crossmatch, respectively. (See
         <a class="local">
          'Laboratory testing'
         </a>
         above and
         <a class="local">
          'Postpartum hemorrhage prophylaxis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antibiotic prophylaxis
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Routine prophylaxis
         </strong>
         – For all patients undergoing cesarean birth, we recommend preoperative antibiotic prophylaxis rather than no prophylaxis or prophylaxis after cord clamping (
         <a class="grade" href="https:///uptodate/show/grade_1" rel="external">
          Grade 1A
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         We administer a single intravenous dose of a narrow-spectrum antibiotic, such as
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         (2 grams for patients &lt;120 kg and 3 grams for patients ≥120 kg) up to 60 minutes before making the incision.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         If the cesarean birth is performed intrapartum or after rupture of membranes, we add a single dose of
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         500 mg intravenously. (See
         <a class="local">
          'Regimen'
         </a>
         above and
         <a class="local">
          'Prolonged surgery or excessive blood loss'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Patients with penicillin allergy
         </strong>
         – For patients with a history of serious forms of penicillin allergy  (
         <a class="graphic graphic_algorithm graphicRef112936" href="/z/d/graphic/112936.html" rel="external">
          algorithm 1
         </a>
         ), we substitute
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         and
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         for
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         . Patients at low risk of a serious immediate allergic reaction can receive cefazolin. If the cesarean birth is performed intrapartum or after rupture of membranes, we add a dose of
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         500 mg intravenously. (See
         <a class="local">
          'Patients with penicillin allergy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For
         <strong>
          patients already receiving
         </strong>
         <a class="drug drug_general" data-topicid="9749" href="/z/d/drug information/9749.html" rel="external">
          penicillin G
         </a>
         <strong>
          for prophylaxis
         </strong>
         <strong>
          of neonatal Group B
         </strong>
         <strong>
          <em>
           Streptococcus
          </em>
         </strong>
         (GBS) infection, we do not add
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         or switch to
         <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">
          ampicillin
         </a>
         for surgical prophylaxis. If the cesarean birth is performed intrapartum or after rupture of membranes, we add a dose of
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         500 mg intravenously. (See
         <a class="local">
          'Patients already on antibiotics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For
         <strong>
          patients receiving
         </strong>
         <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">
          ampicillin
         </a>
         <strong>
          and
         </strong>
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         <strong>
          for chorioamnionitis
         </strong>
         , we add either one dose of
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         900 mg or
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         500 mg before making the incision, and continue ampicillin and gentamicin or switch to
         <a class="drug drug_general" data-topicid="8745" href="/z/d/drug information/8745.html" rel="external">
          ampicillin-sulbactam
         </a>
         postpartum until the patient is afebrile for at least 24 hours.
         <em>
          Bacteroides
         </em>
         resistance to clindamycin is increasing; in areas of high resistance, ampicillin-sulbactam is preferable. We do not administer pre-incision prophylactic
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         in this setting. (See
         <a class="local">
          'Patients already on antibiotics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Skin preparation
         </strong>
         – We use a chlorhexidine-based antiseptic agent rather than an iodine-based antiseptic agent for skin preparation, but either approach is reasonable. Chlorhexidine-alcohol solutions should be allowed to dry for at least three minutes before using an ignition source, otherwise a nonflammable preparation (povidone-iodine or
         <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">
          chlorhexidine
         </a>
         soap) should be used. (See
         <a class="local">
          'Skin preparation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vaginal preparation
         </strong>
         – For patients in labor and patients with ruptured membranes, we suggest vaginal cleansing before cesarean birth rather than no vaginal cleansing (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). We use a 4%
         <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">
          chlorhexidine
         </a>
         gluconate vaginal scrub, but povidone-iodine is also reasonable. (See
         <a class="local">
          'Vaginal preparation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Thromboprophylaxis
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For all patients undergoing cesarean birth, we suggest mechanical thromboprophylaxis (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients undergoing cesarean birth at high risk of venous thromboembolism (VTE), we suggest mechanical thromboprophylaxis plus pharmacologic thromboprophylaxis (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Low-dose pharmacologic prophylaxis is typically started 6 to 12 hours after surgery, in the absence of specific concerns about hemorrhage. Mechanical and pharmacologic prophylaxis are continued until the patient is fully ambulating,
         <strong>
          except
         </strong>
         for those with significant risk factors for postpartum VTE. Patients with a prior VTE receive at least six weeks of thromboprophylaxis. Those with a VTE during the index pregnancy are treated for at least three months and this duration should include the remainder of pregnancy and at least six weeks postpartum. Those with a high risk of thrombophilia may require an indefinite period of anticoagulation. (See
         <a class="local">
          'Thromboembolism prophylaxis'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Osterman MJK, Hamilton BE, Martin JA, et al. Births: Final Data for 2020. Natl Vital Stat Rep 2022; 70:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boerma T, Ronsmans C, Melesse DY, et al. Global epidemiology of use of and disparities in caesarean sections. Lancet 2018; 392:1341.
          </a>
         </li>
         <li class="breakAll">
          WHO recommendations non-clinical interventions to reduce unnecessary caesarean sections http://apps.who.int/iris/bitstream/handle/10665/275377/9789241550338-eng.pdf?ua=1 (Accessed on October 15, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           American College of Obstetricians and Gynecologists (College), Society for Maternal-Fetal Medicine, Caughey AB, et al. Safe prevention of the primary cesarean delivery. Am J Obstet Gynecol 2014; 210:179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Visser GHA, Ayres-de-Campos D, Barnea ER, et al. FIGO position paper: how to stop the caesarean section epidemic. Lancet 2018; 392:1286.
          </a>
         </li>
         <li class="breakAll">
          CMQCC. Toolkit to Support Vaginal Birth and Reduce Primary Cesareans https://www.cmqcc.org/VBirthToolkitResource (Accessed on April 29, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenstein MG, Chang SC, Sakowski C, et al. Hospital Quality Improvement Interventions, Statewide Policy Initiatives, and Rates of Cesarean Delivery for Nulliparous, Term, Singleton, Vertex Births in California. JAMA 2021; 325:1631.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson RD, Caughey AB, Wood SL, et al. Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations (Part 1). Am J Obstet Gynecol 2018; 219:523.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caughey AB, Wood SL, Macones GA, et al. Guidelines for intraoperative care in cesarean delivery: Enhanced Recovery After Surgery Society Recommendations (Part 2). Am J Obstet Gynecol 2018; 219:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Macones GA, Caughey AB, Wood SL, et al. Guidelines for postoperative care in cesarean delivery: Enhanced Recovery After Surgery (ERAS) Society recommendations (part 3). Am J Obstet Gynecol 2019; 221:247.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ACOG Committee Opinion No. 750: Perioperative Pathways: Enhanced Recovery After Surgery. Obstet Gynecol 2018; 132:e120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bollag L, Lim G, Sultan P, et al. Society for Obstetric Anesthesia and Perinatology: Consensus Statement and Recommendations for Enhanced Recovery After Cesarean. Anesth Analg 2021; 132:1362.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corso E, Hind D, Beever D, et al. Enhanced recovery after elective caesarean: a rapid review of clinical protocols, and an umbrella review of systematic reviews. BMC Pregnancy Childbirth 2017; 17:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meng X, Chen K, Yang C, et al. The Clinical Efficacy and Safety of Enhanced Recovery After Surgery for Cesarean Section: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies. Front Med (Lausanne) 2021; 8:694385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sultan P, Sharawi N, Blake L, et al. Impact of enhanced recovery after cesarean delivery on maternal outcomes: A systematic review and meta-analysis. Anaesth Crit Care Pain Med 2021; 40:100935.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyle A, Reddy UM, Landy HJ, et al. Primary cesarean delivery in the United States. Obstet Gynecol 2013; 122:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walker SP, McCarthy EA, Ugoni A, et al. Cesarean delivery or vaginal birth: a survey of patient and clinician thresholds. Obstet Gynecol 2007; 109:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lyerly AD, Mitchell LM, Armstrong EM, et al. Risks, values, and decision making surrounding pregnancy. Obstet Gynecol 2007; 109:979.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sentilhes L, Vayssière C, Beucher G, et al. Delivery for women with a previous cesarean: guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol 2013; 170:25.
          </a>
         </li>
         <li class="breakAll">
          http://www.nice.org.uk/guidance/cg132 (Accessed on October 22, 2014).
         </li>
         <li>
          <a class="nounderline abstract_t">
           American College of Obstetricians and Gynecologists. ACOG committee opinion no. 561: Nonmedically indicated early-term deliveries. Obstet Gynecol 2013; 121:911. Reaffirmed 2017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Committee on Obstetric Practice. Committee Opinion No. 688: Management of Suboptimally Dated Pregnancies. Obstet Gynecol 2017; 129:e29. Reaffirmed 2019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansen AK, Wisborg K, Uldbjerg N, Henriksen TB. Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study. BMJ 2008; 336:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zanardo V, Simbi AK, Franzoi M, et al. Neonatal respiratory morbidity risk and mode of delivery at term: influence of timing of elective caesarean delivery. Acta Paediatr 2004; 93:643.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morrison JJ, Rennie JM, Milton PJ. Neonatal respiratory morbidity and mode of delivery at term: influence of timing of elective caesarean section. Br J Obstet Gynaecol 1995; 102:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wax JR, Herson V, Carignan E, et al. Contribution of elective delivery to severe respiratory distress at term. Am J Perinatol 2002; 19:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yee W, Amin H, Wood S. Elective cesarean delivery, neonatal intensive care unit admission, and neonatal respiratory distress. Obstet Gynecol 2008; 111:823.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clark SL, Miller DD, Belfort MA, et al. Neonatal and maternal outcomes associated with elective term delivery. Am J Obstet Gynecol 2009; 200:156.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilmink FA, Hukkelhoven CW, Lunshof S, et al. Neonatal outcome following elective cesarean section beyond 37 weeks of gestation: a 7-year retrospective analysis of a national registry. Am J Obstet Gynecol 2010; 202:250.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nir V, Nadir E, Feldman M. Late better than early elective term Cesarean section. Acta Paediatr 2012; 101:1054.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glavind J, Kindberg SF, Uldbjerg N, et al. Elective caesarean section at 38 weeks versus 39 weeks: neonatal and maternal outcomes in a randomised controlled trial. BJOG 2013; 120:1123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tita AT, Landon MB, Spong CY, et al. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med 2009; 360:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith J, Plaat F, Fisk NM. The natural caesarean: a woman-centred technique. BJOG 2008; 115:1037.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Magee SR, Battle C, Morton J, Nothnagle M. Promotion of family-centered birth with gentle cesarean delivery. J Am Board Fam Med 2014; 27:690.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Armbrust R, Hinkson L, von Weizsäcker K, Henrich W. The Charité cesarean birth: a family orientated approach of cesarean section. J Matern Fetal Neonatal Med 2016; 29:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacKenzie IZ, Cooke I. Prospective 12 month study of 30 minute decision to delivery intervals for "emergency" caesarean section. BMJ 2001; 322:1334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           James D. Caesarean section for fetal distress. BMJ 2001; 322:1316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Helmy WH, Jolaoso AS, Ifaturoti OO, et al. The decision-to-delivery interval for emergency caesarean section: is 30 minutes a realistic target? BJOG 2002; 109:505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tuffnell DJ, Wilkinson K, Beresford N. Interval between decision and delivery by caesarean section-are current standards achievable? Observational case series. BMJ 2001; 322:1330.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chauhan SP, Roach H, Naef RW 2nd, et al. Cesarean section for suspected fetal distress. Does the decision-incision time make a difference? J Reprod Med 1997; 42:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacKenzie IZ, Cooke I. What is a reasonable time from decision-to-delivery by caesarean section? Evidence from 415 deliveries. BJOG 2002; 109:498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas J, Paranjothy S, James D. National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section. BMJ 2004; 328:665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holcroft CJ, Graham EM, Aina-Mumuney A, et al. Cord gas analysis, decision-to-delivery interval, and the 30-minute rule for emergency cesareans. J Perinatol 2005; 25:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bloom SL, Leveno KJ, Spong CY, et al. Decision-to-incision times and maternal and infant outcomes. Obstet Gynecol 2006; 108:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tolcher MC, Johnson RL, El-Nashar SA, West CP. Decision-to-incision time and neonatal outcomes: a systematic review and meta-analysis. Obstet Gynecol 2014; 123:536.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stallings SP, Edwards RK, Johnson JW. Correlation of head-to-body delivery intervals in shoulder dystocia and umbilical artery acidosis. Am J Obstet Gynecol 2001; 185:268.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katz VL, Dotters DJ, Droegemueller W. Perimortem cesarean delivery. Obstet Gynecol 1986; 68:571.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Myers RE. Two patterns of perinatal brain damage and their conditions of occurrence. Am J Obstet Gynecol 1972; 112:246.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg 2017; 152:784.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stone J, Bianco A, Monro J, et al. Study To Reduce Infection Prior to Elective Cesarean Deliveries (STRIPES): a randomized clinical trial of chlorhexidine. Am J Obstet Gynecol 2020; 223:113.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2015; :CD004985.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Franco LM, Cota GF, Pinto TS, Ercole FF. Preoperative bathing of the surgical site with chlorhexidine for infection prevention: Systematic review with meta-analysis. Am J Infect Control 2017; 45:343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chlebicki MP, Safdar N, O'Horo JC, Maki DG. Preoperative chlorhexidine shower or bath for prevention of surgical site infection: a meta-analysis. Am J Infect Control 2013; 41:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2006; :CD004985.
          </a>
         </li>
         <li class="breakAll">
          Joint Commission. Proposed Standards for Perinatal Safety Hospital (HAP) Accreditation Program https://jointcommission.az1.qualtrics.com/CP/File.php?F=F_2bMhcokkpaksMvz (Accessed on June 11, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013; 70:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tita AT, Szychowski JM, Boggess K, et al. Adjunctive Azithromycin Prophylaxis for Cesarean Delivery. N Engl J Med 2016; 375:1231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 199: Use of Prophylactic Antibiotics in Labor and Delivery. Obstet Gynecol 2018; 132:e103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev 2014; :CD007482.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mackeen AD, Packard RE, Ota E, et al. Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery. Cochrane Database Syst Rev 2014; :CD009516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dinsmoor MJ, Gilbert S, Landon MB, et al. Perioperative antibiotic prophylaxis for nonlaboring cesarean delivery. Obstet Gynecol 2009; 114:752.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ledger WJ, Blaser MJ. Are we using too many antibiotics during pregnancy? BJOG 2013; 120:1450.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forse RA, Karam B, MacLean LD, Christou NV. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 1989; 106:750.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wurtz R, Itokazu G, Rodvold K. Antimicrobial dosing in obese patients. Clin Infect Dis 1997; 25:112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swank ML, Wing DA, Nicolau DP, McNulty JA. Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women. Am J Obstet Gynecol 2015; 213:415.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young OM, Shaik IH, Twedt R, et al. Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery. Am J Obstet Gynecol 2015; 213:541.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maggio L, Nicolau DP, DaCosta M, et al. Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial. Obstet Gynecol 2015; 125:1205.
          </a>
         </li>
         <li class="breakAll">
          www.drugs.com.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams MJ, Carvalho Ribeiro do Valle C, Gyte GM. Different classes of antibiotics given to women routinely for preventing infection at caesarean section. Cochrane Database Syst Rev 2021; 3:CD008726.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopkins L, Smaill F. Antibiotic prophylaxis regimens and drugs for cesarean section. Cochrane Database Syst Rev 2000; :CD001136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pinto-Lopes R, Sousa-Pinto B, Azevedo LF. Single dose versus multiple dose of antibiotic prophylaxis in caesarean section: a systematic review and meta-analysis. BJOG 2017; 124:595.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Markwei MT, Babatunde I, Rathi N, et al. Preincision adjunctive prophylaxis for cesarean deliveries a systematic review and meta-analysis. Am J Obstet Gynecol 2021; 225:382.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harper LM, Kilgore M, Szychowski JM, et al. Economic Evaluation of Adjunctive Azithromycin Prophylaxis for Cesarean Delivery. Obstet Gynecol 2017; 130:328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanusi A, Ye Y, Boggess K, et al. Timing of Adjunctive Azithromycin for Unscheduled Cesarean Delivery and Postdelivery Infection. Obstet Gynecol 2022; 139:1043.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pierce SL, Bisson CM, Dubois ME, et al. Clinical effectiveness of adding azithromycin to antimicrobial prophylaxis for cesarean delivery. Am J Obstet Gynecol 2021; 225:335.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruzic MF, Blanchard CT, Cozzi GD, et al. Adjunctive Azithromycin Prophylaxis for Prelabor Cesarean Birth. Obstet Gynecol 2023; 141:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zelenitsky SA, Silverman RE, Duckworth H, Harding GK. A prospective, randomized, double-blind studyof single high dose versus multiple standard dose gentamicin both in combination withmetronidazole for colorectal surgicalprophylaxis. J Hosp Infect 2000; 46:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rao SC, Srinivasjois R, Hagan R, Ahmed M. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev 2011; :CD005091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fay KE, Yee L. Applying surgical antimicrobial standards in cesarean deliveries. Am J Obstet Gynecol 2018; 218:416.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013; 14:73.
          </a>
         </li>
         <li class="breakAll">
          https://www.cdc.gov/mmwr/preview/mmwrhtml/ss5202a1.htm#tab3 (Accessed on February 14, 2017).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353:1258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bain E, Wilson A, Tooher R, et al. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev 2014; :CD001689.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kotaska A. Postpartum venous thromboembolism prophylaxis may cause more harm than benefit: a critical analysis of international guidelines through an evidence-based lens. BJOG 2018; 125:1109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Friedman AM, D'Alton ME. Expert review: prevention of obstetrical venous thromboembolism. Am J Obstet Gynecol 2021; 225:228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seeho S, Nassar N. Thromboprophylaxis after caesarean: when even the 'experts' disagree. BJOG 2016; 123:2163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Shaughnessy F, Donnelly JC, Cooley SM, et al. Thrombocalc: implementation and uptake of personalized postpartum venous thromboembolism risk assessment in a high-throughput obstetric environment. Acta Obstet Gynecol Scand 2017; 96:1382.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor GM, McKenzie CA, Mires GJ. Use of a computerised maternity information system to improve clinical effectiveness: thromboprophylaxis at caesarean section. Postgrad Med J 2000; 76:354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy. Obstet Gynecol 2018; 132:e1. Reaffirmed 2022.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Committee on Practice Bulletins--Gynecology, American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 84: Prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 2007; 110:429. Reaffirmed 2018.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clark SL, Belfort MA, Dildy GA, et al. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol 2008; 199:36.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clark SL, Christmas JT, Frye DR, et al. Maternal mortality in the United States: predictability and the impact of protocols on fatal postcesarean pulmonary embolism and hypertension-related intracranial hemorrhage. Am J Obstet Gynecol 2014; 211:32.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sibai BM, Rouse DJ. Pharmacologic Thromboprophylaxis in Obstetrics: Broader Use Demands Better Data. Obstet Gynecol 2016; 128:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e691S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dargaud Y, Rugeri L, Vergnes MC, et al. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study. Br J Haematol 2009; 145:825.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Danilenko-Dixon DR, Heit JA, Silverstein MD, et al. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol 2001; 184:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ettema HB, Kollen BJ, Verheyen CC, Büller HR. Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials. J Thromb Haemost 2008; 6:1093.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost 2008; 6:905.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006; 194:1311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindqvist P, Dahlbäck B, Marŝál K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 1999; 94:595.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Macklon NS, Greer IA. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott Med J 1996; 41:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simpson EL, Lawrenson RA, Nightingale AL, Farmer RD. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG 2001; 108:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blondon M, Perrier A, Nendaz M, et al. Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery. Thromb Haemost 2010; 103:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kobayashi T, Nakabayashi M, Ishikawa M, et al. Pulmonary thromboembolism in obstetrics and gynecology increased by 6.5-fold over the past decade in Japan. Circ J 2008; 72:753.
          </a>
         </li>
         <li class="breakAll">
          Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Green-top Guideline No. 37a. April 2015 https://www.rcog.org.uk/globalassets/documents/guidelines/gtg-37a.pdf (Accessed on October 05, 2016).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horlocker TT, Vandermeuelen E, Kopp SL, et al. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition). Reg Anesth Pain Med 2018; 43:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leffert L, Butwick A, Carvalho B, et al. The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants. Anesth Analg 2018; 126:928.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bistervels IM, Buchmüller A, Wiegers HMG, et al. Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial. Lancet 2022; 400:1777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bates SM, Middeldorp S, Rodger M, et al. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis 2016; 41:92.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lurie S, Baider C, Glickman H, et al. Are enemas given before cesarean section useful? A prospective randomized controlled study. Eur J Obstet Gynecol Reprod Biol 2012; 163:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Committee on Obstetric Practice. ACOG Committee Opinion No. 382: Fetal Monitoring Prior to Scheduled Cesarean Delivery. Obstet Gynecol 2007; 110:961.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weingarten SJ, Levy AT, Berghella V. The effect of music on anxiety in women undergoing cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2021; 3:100435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simon VB, Fong A, Nageotte MP. Supplemental Oxygen Study: A Randomized Controlled Study on the Effect of Maternal Oxygen Supplementation during Planned Cesarean Delivery on Umbilical Cord Gases. Am J Perinatol 2018; 35:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li L, Wen J, Wang L, et al. Is routine indwelling catheterisation of the bladder for caesarean section necessary? A systematic review. BJOG 2011; 118:400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdel-Aleem H, Aboelnasr MF, Jayousi TM, Habib FA. Indwelling bladder catheterisation as part of intraoperative and postoperative care for caesarean section. Cochrane Database Syst Rev 2014; :CD010322.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Senanayake H. Elective cesarean section without urethral catheterization. J Obstet Gynaecol Res 2005; 31:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghoreishi J. Indwelling urinary catheters in cesarean delivery. Int J Gynaecol Obstet 2003; 83:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnes JS. Is it better to avoid urethral catheterization at hysterectomy and caesarean section? Aust N Z J Obstet Gynaecol 1998; 38:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nasr AM, ElBigawy AF, Abdelamid AE, et al. Evaluation of the use vs nonuse of urinary catheterization during cesarean delivery: a prospective, multicenter, randomized controlled trial. J Perinatol 2009; 29:416.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Menshawy A, Ghanem E, Menshawy E, et al. Early versus delayed removal of indwelling urinary catheter after elective cesarean delivery: systematic review and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med 2020; 33:2818.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tanner J, Norrie P, Melen K. Preoperative hair removal to reduce surgical site infection. Cochrane Database Syst Rev 2011; :CD004122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lefebvre A, Saliou P, Lucet JC, et al. Preoperative hair removal and surgical site infections: network meta-analysis of randomized controlled trials. J Hosp Infect 2015; 91:100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tuuli MG, Liu J, Stout MJ, et al. A Randomized Trial Comparing Skin Antiseptic Agents at Cesarean Delivery. N Engl J Med 2016; 374:647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kunkle CM, Marchan J, Safadi S, et al. Chlorhexidine gluconate versus povidone iodine at cesarean delivery: a randomized controlled trial. J Matern Fetal Neonatal Med 2015; 28:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Darouiche RO, Wall MJ Jr, Itani KM, et al. Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med 2010; 362:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hadiati DR, Hakimi M, Nurdiati DS, et al. Skin preparation for preventing infection following caesarean section. Cochrane Database Syst Rev 2020; 6:CD007462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lakhi NA, Tricorico G, Osipova Y, Moretti ML. Vaginal cleansing with chlorhexidine gluconateor povidone-iodine prior to cesarean delivery:a randomized comparator-controlled trial. Am J Obstet Gynecol 2019; :2.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haas DM, Morgan S, Contreras K, Kimball S. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst Rev 2020; 4:CD007892.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Temming LA, Frolova AI, Raghuraman N, et al. Vaginal cleansing before unscheduled cesarean delivery to reduce infection: a randomized clinical trial. Am J Obstet Gynecol 2023; 228:739.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roeckner JT, Sanchez-Ramos L, Mitta M, et al. Povidone-iodine 1% is the most effective vaginal antiseptic for preventing post-cesarean endometritis: a systematic review and network meta-analysis. Am J Obstet Gynecol 2019; 221:261.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eckler R, Quist-Nelson J, Saccone G, et al. Adhesive incisional drapes during cesarean delivery for preventing wound infection: A systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol X 2019; 4:100090.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee SW, Khaw KS, Ngan Kee WD, et al. Haemodynamic effects from aortocaval compression at different angles of lateral tilt in non-labouring term pregnant women. Br J Anaesth 2012; 109:950.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bamber JH, Dresner M. Aortocaval compression in pregnancy: the effect of changing the degree and direction of lateral tilt on maternal cardiac output. Anesth Analg 2003; 97:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kundra P, Velraj J, Amirthalingam U, et al. Effect of positioning from supine and left lateral positions to left lateral tilt on maternal blood flow velocities and waveforms in full-term parturients. Anaesthesia 2012; 67:889.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kinsella SM, Harvey NL. A comparison of the pelvic angle applied using lateral table tilt or a pelvic wedge at elective caesarean section. Anaesthesia 2012; 67:1327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Calvache JA, Muñoz MF, Baron FJ. Hemodynamic effects of a right lumbar-pelvic wedge during spinal anesthesia for cesarean section. Int J Obstet Anesth 2011; 20:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cluver C, Novikova N, Hofmeyr GJ, Hall DR. Maternal position during caesarean section for preventing maternal and neonatal complications. Cochrane Database Syst Rev 2013; :CD007623.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 4475 Version 188.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Births: Final Data for 2020
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30322584" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Global epidemiology of use of and disparities in caesarean sections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30322584" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Global epidemiology of use of and disparities in caesarean sections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24565430" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Safe prevention of the primary cesarean delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30322563" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : FIGO position paper: how to stop the caesarean section epidemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30322563" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : FIGO position paper: how to stop the caesarean section epidemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33904868" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Hospital Quality Improvement Interventions, Statewide Policy Initiatives, and Rates of Cesarean Delivery for Nulliparous, Term, Singleton, Vertex Births in California.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30240657" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations (Part 1).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30118692" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Guidelines for intraoperative care in cesarean delivery: Enhanced Recovery After Surgery Society Recommendations (Part 2).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30995461" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Guidelines for postoperative care in cesarean delivery: Enhanced Recovery After Surgery (ERAS) Society recommendations (part 3).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30134426" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : ACOG Committee Opinion No. 750: Perioperative Pathways: Enhanced Recovery After Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33177330" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Society for Obstetric Anesthesia and Perinatology: Consensus Statement and Recommendations for Enhanced Recovery After Cesarean.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28320342" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Enhanced recovery after elective caesarean: a rapid review of clinical protocols, and an umbrella review of systematic reviews.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34409050" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : The Clinical Efficacy and Safety of Enhanced Recovery After Surgery for Cesarean Section: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34390864" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Impact of enhanced recovery after cesarean delivery on maternal outcomes: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23743454" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Primary cesarean delivery in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17197589" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Cesarean delivery or vaginal birth: a survey of patient and clinician thresholds.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17400862" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Risks, values, and decision making surrounding pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23810846" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Delivery for women with a previous cesarean: guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23810846" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Delivery for women with a previous cesarean: guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23635710" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : ACOG committee opinion no. 561: Nonmedically indicated early-term deliveries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28225423" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Committee Opinion No. 688: Management of Suboptimally Dated Pregnancies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18077440" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15174788" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Neonatal respiratory morbidity risk and mode of delivery at term: influence of timing of elective caesarean delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7756199" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Neonatal respiratory morbidity and mode of delivery at term: influence of timing of elective caesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11938481" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Contribution of elective delivery to severe respiratory distress at term.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18378740" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Elective cesarean delivery, neonatal intensive care unit admission, and neonatal respiratory distress.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19110225" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Neonatal and maternal outcomes associated with elective term delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20207243" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Neonatal outcome following elective cesarean section beyond 37 weeks of gestation: a 7-year retrospective analysis of a national registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22758608" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Late better than early elective term Cesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23682628" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Elective caesarean section at 38 weeks versus 39 weeks: neonatal and maternal outcomes in a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19129525" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Timing of elective repeat cesarean delivery at term and neonatal outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18651885" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : The natural caesarean: a woman-centred technique.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25201938" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Promotion of family-centered birth with gentle cesarean delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25572878" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : The Charitécesarean birth: a family orientated approach of cesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11387178" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Prospective 12 month study of 30 minute decision to delivery intervals for "emergency" caesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11387163" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Caesarean section for fetal distress.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12066938" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : The decision-to-delivery interval for emergency caesarean section: is 30 minutes a realistic target?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11387177" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Interval between decision and delivery by caesarean section-are current standards achievable? Observational case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9219122" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Cesarean section for suspected fetal distress. Does the decision-incision time make a difference?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12066937" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : What is a reasonable time from decision-to-delivery by caesarean section? Evidence from 415 deliveries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15023829" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15616612" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Cord gas analysis, decision-to-delivery interval, and the 30-minute rule for emergency cesareans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16816049" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Decision-to-incision times and maternal and infant outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24499762" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Decision-to-incision time and neonatal outcomes: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11518878" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Correlation of head-to-body delivery intervals in shoulder dystocia and umbilical artery acidosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3528956" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Perimortem cesarean delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4621486" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Two patterns of perinatal brain damage and their conditions of occurrence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28467526" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32407786" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Study To Reduce Infection Prior to Elective Cesarean Deliveries (STRIPES): a randomized clinical trial of chlorhexidine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25927093" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Preoperative bathing or showering with skin antiseptics to prevent surgical site infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28109628" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Preoperative bathing of the surgical site with chlorhexidine for infection prevention: Systematic review with meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22722008" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Preoperative chlorhexidine shower or bath for prevention of surgical site infection: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16625619" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Preoperative bathing or showering with skin antiseptics to prevent surgical site infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16625619" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Preoperative bathing or showering with skin antiseptics to prevent surgical site infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23327981" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Clinical practice guidelines for antimicrobial prophylaxis in surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27682034" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Adjunctive Azithromycin Prophylaxis for Cesarean Delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30134425" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : ACOG Practice Bulletin No. 199: Use of Prophylactic Antibiotics in Labor and Delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25350672" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25479008" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19888031" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Perioperative antibiotic prophylaxis for nonlaboring cesarean delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24118809" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Are we using too many antibiotics during pregnancy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2799651" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Antibiotic prophylaxis for surgery in morbidly obese patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9243045" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Antimicrobial dosing in obese patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26003059" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26103528" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25932849" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25932849" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33661539" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Different classes of antibiotics given to women routinely for preventing infection at caesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10796247" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Antibiotic prophylaxis regimens and drugs for cesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27885778" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Single dose versus multiple dose of antibiotic prophylaxis in caesarean section: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33964219" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Preincision adjunctive prophylaxis for cesarean deliveries a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28697108" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Economic Evaluation of Adjunctive Azithromycin Prophylaxis for Cesarean Delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35675601" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Timing of Adjunctive Azithromycin for Unscheduled Cesarean Delivery and Postdelivery Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34052192" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Clinical effectiveness of adding azithromycin to antimicrobial prophylaxis for cesarean delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36649335" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Adjunctive Azithromycin Prophylaxis for Prelabor Cesarean Birth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11049707" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : A prospective, randomized, double-blind studyof single high dose versus multiple standard dose gentamicin both in combination withmetronidazole for colorectal surgicalprophylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22071818" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29353029" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Applying surgical antimicrobial standards in cesarean deliveries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23461695" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Clinical practice guidelines for antimicrobial prophylaxis in surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23461695" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Clinical practice guidelines for antimicrobial prophylaxis in surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10217099" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Thrombosis in pregnancy: maternal and fetal issues.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24519568" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29512316" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Postpartum venous thromboembolism prophylaxis may cause more harm than benefit: a critical analysis of international guidelines through an evidence-based lens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33974905" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Expert review: prevention of obstetrical venous thromboembolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26542607" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Thromboprophylaxis after caesarean: when even the 'experts' disagree.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28832906" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Thrombocalc: implementation and uptake of personalized postpartum venous thromboembolism risk assessment in a high-throughput obstetric environment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10824050" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Use of a computerised maternity information system to improve clinical effectiveness: thromboprophylaxis at caesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29939938" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17666620" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : ACOG Practice Bulletin No. 84: Prevention of deep vein thrombosis and pulmonary embolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18455140" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24631705" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Maternal mortality in the United States: predictability and the impact of protocols on fatal postcesarean pulmonary embolism and hypertension-related intracranial hemorrhage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27607853" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Pharmacologic Thromboprophylaxis in Obstetrics: Broader Use Demands Better Data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22315276" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19388925" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11174488" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18429944" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18363820" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16647915" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10511366" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Thrombotic risk during pregnancy: a population study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8807703" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11213005" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20062923" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18441455" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Pulmonary thromboembolism in obstetrics and gynecology increased by 6.5-fold over the past decade in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18441455" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Pulmonary thromboembolism in obstetrics and gynecology increased by 6.5-fold over the past decade in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29561531" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29099429" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36354038" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26780741" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22516178" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Are enemas given before cesarean section useful? A prospective randomized controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17906046" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : ACOG Committee Opinion No. 382: Fetal Monitoring Prior to Scheduled Cesarean Delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34214717" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : The effect of music on anxiety in women undergoing cesarean delivery: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28838010" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Supplemental Oxygen Study: A Randomized Controlled Study on the Effect of Maternal Oxygen Supplementation during Planned Cesarean Delivery on Umbilical Cord Gases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21176084" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Is routine indwelling catheterisation of the bladder for caesarean section necessary? A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24729285" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Indwelling bladder catheterisation as part of intraoperative and postoperative care for caesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15669989" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Elective cesarean section without urethral catheterization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14643036" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Indwelling urinary catheters in cesarean delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9761161" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Is it better to avoid urethral catheterization at hysterectomy and caesarean section?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19212327" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Evaluation of the use vs nonuse of urinary catheterization during cesarean delivery: a prospective, multicenter, randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30522371" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Early versus delayed removal of indwelling urinary catheter after elective cesarean delivery: systematic review and meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22071812" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Preoperative hair removal to reduce surgical site infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26320612" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Preoperative hair removal and surgical site infections: network meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26844840" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : A Randomized Trial Comparing Skin Antiseptic Agents at Cesarean Delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24849000" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Chlorhexidine gluconate versus povidone iodine at cesarean delivery: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20054046" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32580252" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Skin preparation for preventing infection following caesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Vaginal cleansing with chlorhexidine gluconateor povidone-iodine prior to cesarean delivery:a randomized comparator-controlled trial
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32335895" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36462539" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Vaginal cleansing before unscheduled cesarean delivery to reduce infection: a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30954518" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Povidone-iodine 1% is the most effective vaginal antiseptic for preventing post-cesarean endometritis: a systematic review and network meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31673692" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Adhesive incisional drapes during cesarean delivery for preventing wound infection: A systematic review and meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23059960" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Haemodynamic effects from aortocaval compression at different angles of lateral tilt in non-labouring term pregnant women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12818977" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Aortocaval compression in pregnancy: the effect of changing the degree and direction of lateral tilt on maternal cardiac output.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22646056" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Effect of positioning from supine and left lateral positions to left lateral tilt on maternal blood flow velocities and waveforms in full-term parturients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23003211" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : A comparison of the pelvic angle applied using lateral table tilt or a pelvic wedge at elective caesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21852106" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Hemodynamic effects of a right lumbar-pelvic wedge during spinal anesthesia for cesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23543552" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Maternal position during caesarean section for preventing maternal and neonatal complications.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
